Literature DB >> 21804564

FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.

Patrick-Simon Welz1, Andy Wullaert, Katerina Vlantis, Vangelis Kondylis, Vanesa Fernández-Majada, Maria Ermolaeva, Petra Kirsch, Anja Sterner-Kock, Geert van Loo, Manolis Pasparakis.   

Abstract

Intestinal immune homeostasis depends on a tightly regulated cross talk between commensal bacteria, mucosal immune cells and intestinal epithelial cells (IECs). Epithelial barrier disruption is considered to be a potential cause of inflammatory bowel disease; however, the mechanisms regulating intestinal epithelial integrity are poorly understood. Here we show that mice with IEC-specific knockout of FADD (FADD(IEC-KO)), an adaptor protein required for death-receptor-induced apoptosis, spontaneously developed epithelial cell necrosis, loss of Paneth cells, enteritis and severe erosive colitis. Genetic deficiency in RIP3, a critical regulator of programmed necrosis, prevented the development of spontaneous pathology in both the small intestine and colon of FADD(IEC-KO) mice, demonstrating that intestinal inflammation is triggered by RIP3-dependent death of FADD-deficient IECs. Epithelial-specific inhibition of CYLD, a deubiquitinase that regulates cellular necrosis, prevented colitis development in FADD(IEC-KO) but not in NEMO(IEC-KO) mice, showing that different mechanisms mediated death of colonic epithelial cells in these two models. In FADD(IEC-KO) mice, TNF deficiency ameliorated colon inflammation, whereas MYD88 deficiency and also elimination of the microbiota prevented colon inflammation, indicating that bacteria-mediated Toll-like-receptor signalling drives colitis by inducing the expression of TNF and other cytokines. However, neither CYLD, TNF or MYD88 deficiency nor elimination of the microbiota could prevent Paneth cell loss and enteritis in FADD(IEC-KO) mice, showing that different mechanisms drive RIP3-dependent necrosis of FADD-deficient IECs in the small and large bowel. Therefore, by inhibiting RIP3-mediated IEC necrosis, FADD preserves epithelial barrier integrity and antibacterial defence, maintains homeostasis and prevents chronic intestinal inflammation. Collectively, these results show that mechanisms preventing RIP3-mediated epithelial cell death are critical for the maintenance of intestinal homeostasis and indicate that programmed necrosis of IECs might be implicated in the pathogenesis of inflammatory bowel disease, in which Paneth cell and barrier defects are thought to contribute to intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21804564     DOI: 10.1038/nature10273

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

Review 1.  Anti-TNF therapy in inflammatory bowel diseases: a huge review.

Authors:  L Peyrin-Biroulet
Journal:  Minerva Gastroenterol Dietol       Date:  2010-06

2.  In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.

Authors:  C Becker; M C Fantini; S Wirtz; A Nikolaev; R Kiesslich; H A Lehr; P R Galle; M F Neurath
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis.

Authors:  W C Yeh; J L de la Pompa; M E McCurrach; H B Shu; A J Elia; A Shahinian; M Ng; A Wakeham; W Khoo; K Mitchell; W S El-Deiry; S W Lowe; D V Goeddel; T W Mak
Journal:  Science       Date:  1998-03-20       Impact factor: 47.728

Review 5.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

6.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

7.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

8.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Functional complementation between FADD and RIP1 in embryos and lymphocytes.

Authors:  Haibing Zhang; Xiaohui Zhou; Thomas McQuade; Jinghe Li; Francis Ka-Ming Chan; Jianke Zhang
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

View more
  258 in total

1.  The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair.

Authors:  Kenta Moriwaki; Sakthi Balaji; Thomas McQuade; Nidhi Malhotra; Joonsoo Kang; Francis Ka-Ming Chan
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Programmed necrosis: backup to and competitor with apoptosis in the immune system.

Authors:  Jiahuai Han; Chuan-Qi Zhong; Duan-Wu Zhang
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

3.  IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

Authors:  J Silke; J E Vince
Journal:  Cell Death Differ       Date:  2012-01       Impact factor: 15.828

Review 4.  Non-apoptotic functions of apoptosis-regulatory proteins.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Christina Trojel-Hansen; Guido Kroemer
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

5.  The flick of a switch: which death program to choose?

Authors:  P Vandenabeele; G Melino
Journal:  Cell Death Differ       Date:  2012-07       Impact factor: 15.828

6.  Gut stem cell necroptosis by genome instability triggers bowel inflammation.

Authors:  Ruicong Wang; Hongda Li; Jianfeng Wu; Zhi-Yu Cai; Baizhou Li; Hengxiao Ni; Xingfeng Qiu; Hui Chen; Wei Liu; Zhang-Hua Yang; Min Liu; Jin Hu; Yaoji Liang; Ping Lan; Jiahuai Han; Wei Mo
Journal:  Nature       Date:  2020-03-25       Impact factor: 49.962

Review 7.  Programmed necrosis in the cross talk of cell death and inflammation.

Authors:  Francis Ka-Ming Chan; Nivea Farias Luz; Kenta Moriwaki
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

8.  MyD88 mediates the decision to die by apoptosis or necroptosis after UV irradiation.

Authors:  Erin Harberts; Rita Fishelevich; Juan Liu; Sergei P Atamas; Anthony A Gaspari
Journal:  Innate Immun       Date:  2013-09-18       Impact factor: 2.680

9.  Death domain-associated protein 6 (Daxx) selectively represses IL-6 transcription through histone deacetylase 1 (HDAC1)-mediated histone deacetylation in macrophages.

Authors:  Zhenyu Yao; Qian Zhang; Xia Li; Dezhi Zhao; Yiqi Liu; Kai Zhao; Yin Liu; Chunmei Wang; Minghong Jiang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

10.  Protective roles for caspase-8 and cFLIP in adult homeostasis.

Authors:  Ricardo Weinlich; Andrew Oberst; Christopher P Dillon; Laura J Janke; Sandra Milasta; John R Lukens; Diego A Rodriguez; Prajwal Gurung; Chandra Savage; Thirumala D Kanneganti; Douglas R Green
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.